Coughlin, C M <br/><br/>
Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.  [electronic resource] 

 -  Immunity  Jul 1998 
 - 25-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1074-7613 
<br/><br/><label>Standard No.: </label>10.1016/s1074-7613(00)80585-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Female<br/>Gene Expression<br/>Interferon-gamma--pharmacology<br/>Interleukin-12--therapeutic use<br/>Mammary Neoplasms, Experimental--drug therapy<br/>Melanoma, Experimental--drug therapy<br/>Mice<br/>Mice, Inbred A<br/>Mice, Inbred C3H<br/>Mutagenesis<br/>Neovascularization, Pathologic<br/>Receptors, Interferon--genetics<br/>Recombinant Proteins<br/>Tumor Cells, Cultured<br/>Interferon gamma Receptor